Replies to post #198705 on Cytodyn Inc (CYDY)

[Saltz]

I pray you are right. There is value in LL. Completing a successful trial and navigating the FDA process has been the hurdle.

[3X Charm]

LL may not treat the new strain of CoVID. Heath care professionals are pivoting away from MABS in light of new studies. As I said before, the CoVID play is over for Cydy. They are too far behind competition and the virus is evolving. The sunk cost in this mess makes Nader’s Prostagen debacle look like a grain of sand.

$300,000,000 pissed away in 3:years for nothing.